Source: BioSpace

ProciseDx: ProciseDx Announces Acquisition by Biosynex S.A. to Transform Biologics Therapeutic Drug Monitoring in the US

ProciseDx Inc. announces that it is being acquired by Biosynex S.A., a French diagnostics company that specializes in point of care testing.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Peter Westlake's photo - CEO of ProciseDx

CEO

Peter Westlake

CEO Approval Rating

90/100

Read more